Dr. John N. Greene, MD

Dr. Greene practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Greene's NPI, 1750306072, was assigned on July 13, 2006. Dr. Greene graduated from USF Health Morsani College of Medicine in 1986. Dr. Greene holds Florida license ME50982.

Dr. Greene's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Greene's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Greene to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Greene practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Greene's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Greene is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Greene's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists pneumonia among the conditions Dr. Greene treats.

CMS data shows 724 Medicare services from Dr. Greene across 2 procedure codes in 2024, for 123 Medicare patients. Medicare paid $48,200 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Greene in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Greene's median patient age at 69, with 42% women.

In 2024, Dr. Greene wrote 104 Medicare Part D claims for 30 patients. 98% of them were for generic drugs. CMS names the drug for 35 of them, across 1 drug with 11 or more claims each, at $704 in total drug cost. In 2023, CMS named 113 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Greene for performance year 2024, reported as part of a group. Dr. Greene accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 160 papers to Dr. Greene, published from 2006 to 2025. 2021 was the busiest year, with 15. The most frequent topics are Anti-Bacterial Agents, Immunocompromised Host and Antifungal Agents. Dr. Greene has published most often in Cancer Control. Dr. Greene's most frequent co-authors are Ramon Sandin, MD, Sowmya Nanjappa, MD and Abraham Tareq Yacoub, MD.

CMS Open Payments shows 4 general payments to Dr. Greene from 2 drug and device companies from 2017 to 2023. Education make up the largest share, 79% of the total. Astellas Pharma US Inc paid the most, $82.

Dr. Greene graduated from USF Health Morsani College of Medicine in 1986.

Dr. Greene is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.